CensorshipBureau @CensorshipBureau@social.privacytools.io
@dredmorbius @isagalaev @kravietz Israelis who had an infection were more protected against the Delta coronavirus variant than those who had an already highly effective COVID-19 vaccine
@dredmorbius @isagalaev @kravietz The presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781098/?report=reader
@dredmorbius @isagalaev @kravietz you are estimating that based on what exactly? several studies show robust post-infection immunity for >6 months, e.g.
The study estimated the efficacy of natural infection against reinfection at 95.2% by comparing SARS-CoV-2 incidence in those antibody-positive to those antibody-negative... Remarkably, this efficacy estimate is similar to the efficacy reported for the two mRNA COVID-19 vaccines
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00141-3/fulltext
@isagalaev @kravietz @dredmorbius how many other diseases with 99.5% survival rate have significantly affected human evolution?
@sunflower_avenue too much CO2 and too dry. Are you growing them in a tent or out on the open?
